NO20005286D0 - Treatment of general anxiety disorders with paroxetine - Google Patents

Treatment of general anxiety disorders with paroxetine

Info

Publication number
NO20005286D0
NO20005286D0 NO20005286A NO20005286A NO20005286D0 NO 20005286 D0 NO20005286 D0 NO 20005286D0 NO 20005286 A NO20005286 A NO 20005286A NO 20005286 A NO20005286 A NO 20005286A NO 20005286 D0 NO20005286 D0 NO 20005286D0
Authority
NO
Norway
Prior art keywords
paroxetine
treatment
anxiety disorders
general anxiety
general
Prior art date
Application number
NO20005286A
Other languages
Norwegian (no)
Other versions
NO20005286L (en
Inventor
Rocco Zaninelli
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20005286D0 publication Critical patent/NO20005286D0/en
Publication of NO20005286L publication Critical patent/NO20005286L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20005286A 1998-04-22 2000-10-20 Treatment of general anxiety disorders with paroxetine NO20005286L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9808479.1A GB9808479D0 (en) 1998-04-22 1998-04-22 Method of treatment
PCT/US1999/008786 WO1999053919A1 (en) 1998-04-22 1999-04-22 Treatment of generalized anxiety disorder with paroxetine

Publications (2)

Publication Number Publication Date
NO20005286D0 true NO20005286D0 (en) 2000-10-20
NO20005286L NO20005286L (en) 2000-12-20

Family

ID=10830715

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005286A NO20005286L (en) 1998-04-22 2000-10-20 Treatment of general anxiety disorders with paroxetine

Country Status (20)

Country Link
EP (1) EP1073437A4 (en)
JP (1) JP2002512189A (en)
KR (1) KR20010034817A (en)
CN (1) CN1298301A (en)
AP (1) AP2000001959A0 (en)
AU (1) AU3864899A (en)
BG (1) BG104939A (en)
BR (1) BR9909791A (en)
CA (1) CA2328896A1 (en)
CZ (1) CZ20003885A3 (en)
EA (1) EA200001088A1 (en)
GB (1) GB9808479D0 (en)
HU (1) HUP0101350A3 (en)
ID (1) ID27546A (en)
IL (1) IL139167A0 (en)
NO (1) NO20005286L (en)
PL (1) PL343494A1 (en)
SK (1) SK15672000A3 (en)
TR (1) TR200003082T2 (en)
WO (1) WO1999053919A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2297550B (en) * 1995-02-06 1997-04-09 Smithkline Beecham Plc Paroxetine hydrochloride anhydrate substantially free of bound organic solvent
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation

Also Published As

Publication number Publication date
EP1073437A1 (en) 2001-02-07
CZ20003885A3 (en) 2001-09-12
PL343494A1 (en) 2001-08-27
BR9909791A (en) 2000-12-26
ID27546A (en) 2001-04-12
WO1999053919A1 (en) 1999-10-28
KR20010034817A (en) 2001-04-25
HUP0101350A2 (en) 2002-05-29
HUP0101350A3 (en) 2002-06-28
CA2328896A1 (en) 1999-10-28
SK15672000A3 (en) 2001-04-09
JP2002512189A (en) 2002-04-23
GB9808479D0 (en) 1998-06-17
AU3864899A (en) 1999-11-08
EA200001088A1 (en) 2001-04-23
AP2000001959A0 (en) 2000-12-31
EP1073437A4 (en) 2003-04-16
IL139167A0 (en) 2001-11-25
TR200003082T2 (en) 2001-01-22
NO20005286L (en) 2000-12-20
BG104939A (en) 2001-09-28
CN1298301A (en) 2001-06-06

Similar Documents

Publication Publication Date Title
NO20021845L (en) Treatment of sleep disorders using desloratadine
NO993051D0 (en) Intranasal formulations for the treatment of sexual disorders
NO20005884L (en) Combination therapy for the treatment of bipolar disorders
DE69936335D1 (en) USE OF MORPHOLINOL FOR THE TREATMENT OF SEXUAL FUNCTIONAL DISORDERS
NO20026263L (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
EE200200442A (en) Piperazine and piperidine derivatives for the treatment of neuronal disorders
DE50014041D1 (en) USE OF EPINASTINE FOR THE TREATMENT OF ALLERGIC RHINITIS / CONJUNCTIVITIS
DE60022867D1 (en) 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine Derivatives for the treatment of CNS disorders
NO20020062D0 (en) Treatment of neurotic disorders
ID27214A (en) TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
NO20032156L (en) Treatment of anxiety disorders
NO20010390D0 (en) Treatment of anxiety disorders
ATE292107T1 (en) USE OF CARBONYLAMIN DERIVATIVES AGAINST CENTRAL NERVOUS SYSTEM DISORDERS
NO20023803D0 (en) Use of mirtazapine for the treatment of sleep disorders
ATE230741T1 (en) 3-TETRAHYDROPYRIDINE-4-YL-INDOLE FOR THE TREATMENT OF PSYCHOTIC DISORDERS
NO20005216D0 (en) Composition for the treatment of external secretion disorders except hypolacrimation
NO20012612D0 (en) Isonipecotamides for the treatment of integrin-mediated disorders
EE200200670A (en) S-methyldihydroziprasidone for the treatment of psychiatric and ocular disorders
NO20005286L (en) Treatment of general anxiety disorders with paroxetine
NO20022244L (en) Treatment of SLE with dehydroepiandrosterone
NO20012538D0 (en) Use of N-substituted azabicycloalkane derivatives for the treatment of central nervous system disorders
DK82798A (en) Treatment of GABA-uptake related disorders

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application